![Jaganathan Jayaseelan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Jaganathan Jayaseelan
Entité | Type d'entité | Industrie | |
---|---|---|---|
Saimirra Innopharm Pvt Ltd.
![]() Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan.
1
| Private Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jaganathan Jayaseelan via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Nuray Chemicals Pvt Ltd.
![]() Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Pharmaceuticals: Major | Director/Board Member | |
Novitium Pharma LLC
![]() Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Pharmaceuticals: Other | Founder | |
ANI PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Tamil Nadu Dr. M.G.R. Medical University | College/University | Graduate Degree | |
JSS College of Pharmacy | College/University | Graduate Degree |
Statistiques
Internationale
Inde | 4 |
Etats-Unis | 3 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Opérationnelle
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 2 |
Chief Operating Officer | 1 |
Founder | 1 |
Relations les plus connectées
Insiders | |
---|---|
Muthusamy Shanmugam | 6 |
- Bourse
- Insiders
- Jaganathan Jayaseelan
- Connexions Sociétés